Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 23, 2024
PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19)
Rahul Aggarwal, Glenn Heller, David W Hillman, et al.
European Journal of Haematology
|
January 29, 2008
Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndrome
Angela Dispenzieri, Martha Q Lacy, Suzanne R Hayman, et al.
Science Translational Medicine
|
January 11, 2023
Genome-wide analysis of aberrant position and sequence of plasma DNA fragment ends in patients with cancer
Karan K Budhraja, Bradon R McDonald, Michelle D Stephens, et al.
JCO Precision Oncology
|
November 15, 2021
Differential Activity of PARP Inhibitors in <i>BRCA1</i>- Versus <i>BRCA2</i>-Altered Metastatic Castration-Resistant Prostate Cancer
Fadi Taza, Albert E Holler, Wei Fu, et al.
JCO Oncology Practice
|
December 19, 2024
Implementation of Universal Germline Genetic Testing Into Standard of Care for Patients With Prostate Cancer: The Time Is Now
Neal Shore, Sarah M Nielsen, Edward D Esplin, et al.
The Lancet. Oncology
|
March 22, 2015
Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial
Jeffrey S Weber, Sandra P D'Angelo, David Minor, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 12, 2022
NCCN Guidelines® Insights: Prostate Cancer, Version 1.2023
Edward M Schaeffer, Sandy Srinivas, Nabil Adra, et al.
European Urology Oncology
|
December 10, 2023
Co-occurring BRCA2/SPOP Mutations Predict Exceptional Poly (ADP-ribose) Polymerase Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate Cancer
Jacob J Orme, Fadi Taza, Navonil De Sarkar, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 19, 2023
Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology
Edward M Schaeffer, Sandy Srinivas, Nabil Adra, et al.
Cancer Cell
|
November 18, 2022
Evaluation of cell-free DNA approaches for multi-cancer early detection
Arash Jamshidi, Minetta C Liu, Eric A Klein, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 23, 2024
PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19)
Rahul Aggarwal, Glenn Heller, David W Hillman, et al.
European Journal of Haematology
|
January 29, 2008
Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndrome
Angela Dispenzieri, Martha Q Lacy, Suzanne R Hayman, et al.
Science Translational Medicine
|
January 11, 2023
Genome-wide analysis of aberrant position and sequence of plasma DNA fragment ends in patients with cancer
Karan K Budhraja, Bradon R McDonald, Michelle D Stephens, et al.
JCO Precision Oncology
|
November 15, 2021
Differential Activity of PARP Inhibitors in <i>BRCA1</i>- Versus <i>BRCA2</i>-Altered Metastatic Castration-Resistant Prostate Cancer
Fadi Taza, Albert E Holler, Wei Fu, et al.
JCO Oncology Practice
|
December 19, 2024
Implementation of Universal Germline Genetic Testing Into Standard of Care for Patients With Prostate Cancer: The Time Is Now
Neal Shore, Sarah M Nielsen, Edward D Esplin, et al.
The Lancet. Oncology
|
March 22, 2015
Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial
Jeffrey S Weber, Sandra P D'Angelo, David Minor, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 12, 2022
NCCN Guidelines® Insights: Prostate Cancer, Version 1.2023
Edward M Schaeffer, Sandy Srinivas, Nabil Adra, et al.
European Urology Oncology
|
December 10, 2023
Co-occurring BRCA2/SPOP Mutations Predict Exceptional Poly (ADP-ribose) Polymerase Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate Cancer
Jacob J Orme, Fadi Taza, Navonil De Sarkar, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 19, 2023
Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology
Edward M Schaeffer, Sandy Srinivas, Nabil Adra, et al.
Cancer Cell
|
November 18, 2022
Evaluation of cell-free DNA approaches for multi-cancer early detection
Arash Jamshidi, Minetta C Liu, Eric A Klein, et al.
Page
of 3